Related Experiment Video
Updated: Feb 14, 2026

Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry
Published on: January 12, 2018
Management of red blood cell alloimmunization in pregnancy
L Ghesquière1, C Garabedian1, C Coulon1
1CHU de Lille, department of obstetrics, 59000 Lille, France.
Abstract:
The main cause of fetal anemia is maternal red blood cell alloimmunization (AI). The search of maternal antibodies by indirect antiglobulin test allows screening for AI during pregnancy. In case of AI, fetal genotyping (for Rh-D, Rh-c, Rh-E and Kell), quantification (for anti-rhesus antibodies) and antibody titration, as well as ultrasound monitoring, are performed. This surveillance aims at screening for severe anemia before hydrops fetalis occurs. Management of severe anemia is based on intrauterine transfusion (IUT) or labor induction depending on gestational age. After intrauterine transfusion, follow-up will focus on detecting recurrence of anemia and detecting fetal brain injury. With IUT, survival of fetuses with alloimmunization is greater than 90% but 4.8% of children with at least one IUT have neurodevelopmental impairment.
Related Concept Videos
Red Algae
Tonsillitis II: Management
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Impression Management Techniques I: Managing Appearances
Managing Impressions
Management of Insomnia

